ライフサイエンスコーパス: mannitol

1 yose, and maltotriose), and a sugar alcohol (mannitol).

2 ae strain to efficiently metabolize DEHU and mannitol.

3 f alpha, beta, delta, and amorphous forms of mannitol.

4 salicylic acid treatment and challenges with mannitol.

5 on, relative hypothermia and possibly use of mannitol.

6 fectively increased by induction with 600 mM mannitol.

7 A synthesis, prevented stromule induction by mannitol.

8 ter discharge response to hypertonic NaCl vs mannitol.

9 ic saline, and 40% (2,500 of 6,238) received mannitol.

10 et aggregation could be mimicked by infusing mannitol.

11 essed during growth on all sugars other than mannitol.

12 ), with both favoring hypertonic saline over mannitol.

13 (14)C]Suc and (14)CO(2), but not from [(14)C]mannitol.

14 catalyze the uptake and phosphorylation of d-mannitol.

15 are amplified with intravenous injection of mannitol.

16 iose, and trehalose and two transporters for mannitol.

17 sized in 13 steps from di-O-isopropylidene-d-mannitol.

18 with intracranial hypertension refractory to mannitol.

19 s 2- to 3-fold that in the presence of 75 mM mannitol.

20 croscopy and differences in the transport of mannitol.

21 while 2.16-fold FPF value of the non-porous mannitol.

22 the presence and absence of high glucose or mannitol.

23 educed at lower turgor after the addition of mannitol.

24 d by intrathecal co-infusion of hyperosmolar mannitol.

25 ed by auxin, but did not respond to salt and mannitol.

26 neurons are responsive to hypertonic NaCl or mannitol.

27 ase in discharge frequency than equi-osmotic mannitol.

28 ar discrimination of different polymorphs of mannitol.

29 either 135 mm NaCl, or a non-NaCl osmolyte, mannitol (0.5%); both increased lumbar sympathetic nerve

30 (traumatic brain injury-saline group) or 20% mannitol (1 g/kg) (traumatic brain injury-mannitol group

31 )F]FDF), 1-deoxy-1-[(18)F]fluoro-2,5-anhydro-mannitol (1-[(18)F]FDAM), 2-deoxy-2-[(18)F]fluoro-d-gluc

32 n PBS; and group 4, intravenous injection of mannitol (1.5 g/kg) in PBS followed by intraarterial inj

33 25 mmol/L d-glucose, but not to iso-osmolar mannitol, 1) reduced the ability of L-ASA to inhibit pla

34 charge to both hypertonic NaCl (+7.5 mm) and mannitol (+15 mm).

35 permeability markers [ionic conductance (G), mannitol, 182 Da; horseradish peroxidase, 40 kDa] and gl

36 The active site of mannitol 2-dehydrogenase from Pseudomonas fluorescens (P

37 dexamethasone (0.2%), ciprofloxacin (0.3%), mannitol (20%), and glucose solution (20%) were examined

38 The administration of mannitol 24h after BCM-PTX injection further improved th

39 so measured before and after intraperitoneal mannitol 25% (2.5 g/kg) administration with mice in a ho

40 100 mm Hg and heart rate <100 beats/min plus mannitol (250 mg/kg) for intracranial hypertension.

41 significantly faster than those treated with mannitol 30 min or more before clamping the renal artery

42 mmol/l d-glucose) but not to osmotic control mannitol (30 mmol/l) switched angiotensin II-stimulated

43 ind, randomized, controlled trial of inhaled mannitol, 400 mg twice a day (n = 192, "treated" group)

44 Inhaled mannitol, 400 mg twice a day, resulted in improved lung

45 ntracranial hypertension-directed therapies (mannitol, 56% vs 21%; hypertonic saline, 14% vs 7%; hypo

46 rose -6.92, dimethylsulphoxide (DMSO) -9.72, mannitol -6.69, trehalose -10.6, NaCl -11.0, glycine -14

47 on of 14 compounds: proline, phloroglucinol, mannitol, 8 fatty acids and 3 sterols.

48 deoxy-3-O-alpha-d-glucopyranosyl-2,5-imino-d-mannitol (9) to act as an inhibitor of GlgE.

49 t GATA4 protein expression (NG, 100 +/- 12%; mannitol, 97 +/- 8%, versus HG, 43 +/- 16%, p < 0.05).

50 xalate simultaneously with the flux of [(3)H]mannitol, a marker of the paracellular pathway, across i

51 siveness to acidic pH and cis-diols (such as mannitol, a safe FDA approved drug for diuresis) through

52 cal resistance, an increase in the efflux of mannitol across the monolayer, and a loss of intracellul

53 f resulting average pore sizes showed that D-mannitol addition resulted in larger average pore size (

54 Specifically, we reduced the time of mannitol administration from 30 to 15 min or less before

55 terial PCO2, change in sevoflurane dose, and mannitol administration had no significant effect on int

56 T revealed that this change in the timing of mannitol administration protected the human donor proxim

57 Treatment with mannitol after traumatic brain injury reversed all these

58 ine (PBS); group 2, intravenous injection of mannitol alone in PBS (1.5 g/kg); group 3, intraarterial

59 Two polymorphs of D-mannitol, alpha and delta, when grown in the presence of

60 Infusion of mannitol also resulted in a greater increase in tissue N

61 ventricular CSF with reference molecules 14C-mannitol and blue dextran.

62 tly higher AUC0-8h value than the non-porous mannitol and commercial product Pulmicort.

63 this platform was further adapted to grow on mannitol and DEHU under anaerobic conditions, it was cap

64 it was capable of ethanol fermentation from mannitol and DEHU, achieving titres of 4.6% (v/v) (36.2

65 obtained, and airway hyperresponsiveness to mannitol and fraction of exhaled nitric oxide values wer

66 Conversion of photoassimilate into mannitol and glycerol for carbon sequestration and osmol

67 The results underline that mannitol and ionic conductance G cannot be considered ma

68 al perfusion pressure was not restored until mannitol and pressor therapy were initiated at 120 mins.

69 ion, we determined the kinetic parameters of mannitol and sorbitol dehydrogenases encoded in the yeas

70 nome, showing that they discriminate between mannitol and sorbitol to a much higher degree than the t

71 xt17 transport two major hexitols in nature, mannitol and sorbitol, with moderate affinities, by a fa

72 er SB permeability (based on 0-2 h levels of mannitol and the lactulose:mannitol ratio); SB permeabil

73 rbia, intravenous pentobarbital, intravenous mannitol and vasopressor titration for maintenance of ce

74 R,R)-hexa-1,5-diene-3,4-diol (derived from D-mannitol) and its enantiomer (derived from l-(+)-tartrat

75 mass transfer coefficients of mannitol (MTC(mannitol)) and albumin (MTC(BSA)), osmotic filtration fl

76 ifferences in thickness, vessel density, MTC(mannitol), and MTC(BSA) among the groups at the various

77 paration solutions (NaCl 0.9%, glycerol 12%, mannitol), and two biopsy forceps (standard and jumbo) i

78 choline responders (n = 74) were negative to mannitol, and 16% of mannitol responders (n = 76) were n

79 creasing medium tonicity with NaCl, sucrose, mannitol, and choline chloride stimulated S100A4 express

80 Sorbitol, mannitol, and galactitol were converted via 1,6-tritylat

81 abundant sugars in macroalgae are alginate, mannitol, and glucan, and although several classes of en

82 5-hydroxymethylfurfural, xylitol, sorbitol, mannitol, and gluconic acid as biorefinery platform chem

83 of three additional PTS sugars: cellobiose, mannitol, and N-acetyl-D-galactosamine.

84 ce, secretory flux of oxalate was similar to mannitol, and no net flux of oxalate occurred.

85 nanoparticles and a hyperosmolar solution of mannitol, and pre-infusion of an isotonic buffer solutio

86 bacteria and yeasts to overproduce xylitol, mannitol, and sorbitol.

87 D-glucose, D-fructose, saccharin, D-mannitol, and water were infused for 3 hours, before har

88 del in which, when carbon sources other than mannitol are present, MtlS sRNA is transcribed, base pai

89 Hypertonic saline and mannitol are used less in infants than in older children

90 We therefore suggest mannitol as a basis for a dual mechanism therapeutic age

91 al barrier breakdown was assessed using (3)H-mannitol as a tracer.

92 e, given as intermittent boluses, has joined mannitol as an effective means of reducing cerebral edem

93 suggest that care should be taken when using mannitol as an osmoticum.

94 Ac, 7 mg/kg) to inhibit O-GlcNAc removal, or mannitol as control.

95 ls were treated with high glucose (30 mm) or mannitol as osmotic control.

96 [Malus domestica]), and one that transports mannitol (Asarina scandens).

97 Among these samples, mannitol based proniosome powder (MAPP) produced small v

98 D-Mannitol belongs to a large and growing family of crysta

99 herapy should be instituted with intravenous mannitol boluses.

100 cholate (CCFA-HT), and cycloserine-cefoxitin mannitol broth with taurocholate and lysozyme (CCMB-TAL)

101 sociated with airway eosinophilia and AHR to mannitol but not airway neutrophilia.

102 indicate that an antiedematous agent such as mannitol can improve brain tissue oxygenation, possibly

103 extensive re-engineering of the alginate and mannitol catabolic pathways in the standard industrial m

104 ry bacterial alginate and deregulated native mannitol catabolism genes, conferred the ability of an S

105 a positive methacholine (PC20 < 8 mg/mL) or mannitol challenge (PD15 < 635 mg), and 30% were non-res

106 th dry air was conducted in 42 players and a mannitol challenge in 18 players.

107 re carried out: spirometry, methacholine and mannitol challenge, exhaled nitric oxide (FeNO); Asthma

108 role of direct (methacholine) and indirect (mannitol) challenge testing in community managed asthma.

109 In random order, methacholine or mannitol challenges were performed 24 h pre- and post-al

110 patterns were observed for compounds such as mannitol, citrate, and alpha-hydroxyisobutyrate and conf

111 not correlate with (45)Ca(2+) absorption or mannitol clearance.

112 bsorption of glucose, water and calcium, and mannitol clearance.

113 nsient, hyperemic response to IC infusion of mannitol compared to normal saline.

114 at formation of the productive enzyme-NAD(+)-mannitol complex is promoted by a corresponding position

115 immediately preceding catalytic oxidation of mannitol, consistent with the notion that formation of t

116 gh molecular weight auxiliary excipients and mannitol containing formulations were unstable and cryst

117 Mannitol content in freeze-dried U. pinnatifida was also

118 We compared mannitol content, sensory quality and volatile profiles

119 In this study, D-mannitol crystals were mixed with photocrosslinkable met

120 D-mannitol crystals were observed to dissolve and leave th

121 deoxy-3-O-alpha-D-glucopyranosyl-2,5-imino-D-mannitol (DDGIM), an oxocarbenium mimic, was solved to 2

122 ased in a high C/N ratio, while fructose and mannitol decreased.

123 ble bioorthogonal chemistries, we conjugated mannitol dehydrogenase to formate dehydrogenase with the

124 itol, coexpression of formate dehydrogenase, mannitol dehydrogenase, and a glucose facilitator protei

125 ct (-)-gracilioether F is described from a d-mannitol derived known compound.

126 d olefinic amides that uses a C(2)-symmetric mannitol-derived cyclic selenium catalyst and a stoichio

127 s between d-arabinose-derived nitrones and d-mannitol-derived trans-olefins have been utilized to syn

128 Equal amount of mannitol did not affect GATA4 protein expression (NG, 10

129 with carboxymethylcellulose (CMC), although mannitol did not form our micro-structures so was discou

130 The solution properties of d-Mannitol (DM) were studied to explore sweetness response

131 dministered to a Parkinson Drosophila model, mannitol dramatically corrected its behavioral defects a

132 ICA infusions of hypertonic NaCl and mannitol each significantly (P < 0.01-0.001) increased t

133 Mannitol enabled the complex to be lyophilized to yield

134 (e.g., lactulose) and sugar alcohols (e.g., mannitol), establishing a differential probe.

135 nsit, mucosal permeability (by lactulose and mannitol excretion), and cytokine production by peripher

136 pharmacokinetic studies since the nanoporous mannitol exhibited a significantly higher AUC0-8h value

137 n acidic pH environment or by administrating mannitol, facilitating drug release in an acidic tumor e

138 n depletion by local perfusion with isotonic mannitol failed to reduce the gating charge further.

139 analyzed pHis peptides from glycerol-fed and mannitol-fed Escherichia coli cells.

140 opy, informs the cooperative organization of mannitol fibers.

141 4 patients who received hypertonic saline or mannitol for >/= 2 days in the first week of therapy, 29

142 ervations included the following: dry powder mannitol for inhalation as a bronchial provocation test

143 ined systolic blood pressure >100 mm Hg plus mannitol for intracranial hypertension.

144 pertonic saline solutions may be superior to mannitol for the treatment of elevated intracranial pres

145 olar doses of hypertonic sodium solutions to mannitol for the treatment of elevated intracranial pres

146 hat hypertonic saline is more effective than mannitol for the treatment of elevated intracranial pres

147 Results indicated that crystalline mannitol fractured at the hydrophilic (011) plane, as ob

148 rategy to overcome the current limitation of mannitol fragmentation and provide improvements in table

149 ure were investigated by adding and removing mannitol from the bathing solution.

150 for germination, and carbon sources such as mannitol, fructose, sorbitol, raffinose and stachyose fo

151 challenge decreased airway responsiveness to mannitol; geometric mean (95% CI) dose-response ratio wa

152 0% mannitol (1 g/kg) (traumatic brain injury-mannitol group).

153 Sham-saline and sham-mannitol groups received no insult.

154 s layers in bovine and porcine models was 3H-mannitol > fluorescein > budesonide > celecoxib > rhodam

155 ecoxib > rhodamine 6G, with HPbetaCD, and 3H-mannitol > fluorescein > rhodamine 6G, without HPbetaCD.

156 In the absence of traumatic brain injury, mannitol had no effect on brain oxygenation.

157 It appears that mannitol has a general neuroprotective effect in the tra

158 eterioration as well as the effects of salt, mannitol, heat, cold, and abscisic acid (ABA) with and w

159 andard cooling rate induced the formation of mannitol hemihydrate, and a secondary drying temperature

160 siologic pH, and of three marker solutes, 3H-mannitol (hydrophilic, neutral), sodium fluorescein (hyd

161 e protocol for intravenous administration of mannitol (i.e., 12.5 or 25 g) to the donor.

162 present study, we tested the hypothesis that mannitol improves the efficiency of intraarterial MSC de

163 fusion of equal volumes of normal saline and mannitol in our rabbit IC drug delivery model.

164 in ZO-1 enhanced permeability to oxalate and mannitol in parallel.

165 assess the fracture behaviour of crystalline mannitol in relation to the energy input during direct c

166 tibody from the CSF, with intrathecal 0.75 m mannitol increasing the number of perivascular profiles

167 lants had higher contents of polyphenols and mannitol indicating that agronomic application of OMW wi

168 ntrations of NaCl, KCl, and LiCl and also to mannitol-induced osmotic stress.

169 lood flow and brain metabolism occur with IA mannitol infusion.

170 and metabolic response to intraarterial (IA) mannitol infusions in order to optimize the delivery of

171 Dimethylthiourea but not mannitol inhibited IL-8 induction by ESAT-6, further sup

172 Although low concentration of mannitol inhibited the formation of fibrils, high concen

173 that the volume but not the flow rate of the mannitol injection has a significant effect on the degre

174 ortex and spinal cord; prior intraperitoneal mannitol injection increased CNS gene delivery tenfold.

175 changes returned to baseline within 5min of mannitol injection.

176 ed either just before, or concurrent with IA mannitol injections.

177 e flux of oxalate in duodenum was similar to mannitol, insensitive to DIDS, and nonsaturable, indicat

178 Mannitol is a six-carbon sugar alcohol that accumulates

179 Mannitol is an essential excipient employed in orally di

180 The loss in responsiveness to mannitol is likely not explainable by a refractory state

181 The addition of excipients such as mannitol is optimized for both the stabilization of prot

182 wo polymorphic forms of the small molecule d-mannitol is presented.

183 pBoB, LDA statistically segregated lactulose/mannitol (L/M) ratios from 0.1 to 0.5, consistent with v

184 leven additives (trehalose, glycine betaine, mannitol, L-Arginine, potassium citrate, CuCl(2), prolin

185 We examined lactulose:mannitol (Lac:Man) permeability in obese individuals wit

186 our different carriers, namely maltodextrin, mannitol, lactose and pullulan.

187 l to determine mass transfer coefficients of mannitol (MTC(mannitol)) and albumin (MTC(BSA)), osmotic

188 Vessel density, MTC(mannitol), MTC(BSA), and J(osm) were dependent on inject

189 treatment with different elicitors (sucrose, mannitol, NaCl, 1-aminocyclopropane-L-carboxylic acid, s

190 ith their higher contents in phloroglucinol, mannitol, oleic, arachidonic and eicosapentaenoic acids,

191 ith their higher contents in phloroglucinol, mannitol, oleic, arachidonic and eicosapentaenoic acids,

192 vitro studies, we demonstrated the effect of mannitol on alpha-synuclein aggregation.

193 equivalent) to investigate 1) the effect of mannitol on brain edema and oxygenation, using a multipa

194 gated the effects of the antiedematous agent mannitol on brain tissue oxygenation in a model of diffu

195 he cortex and caudoputamen; 2) the effect of mannitol on brain tissue PO2 and on venous oxygen satura

196 ction of Ec-MtlR with the well characterized mannitol operator/promoter region.

197 The expression of the mannitol operon is regulated by a proposed transcription

198 ulated by a proposed transcriptional factor, mannitol operon repressor (MtlR) that was first studied

199 Specifically, the mannitol operon sRNA (MtlS sRNA; previously designated t

200 to salt stress and osmotic stress imposed by mannitol or polyethylene glycol in culture media or by w

201 Mannitol (osmolyte) synthesis did not affect exchange or

202 e hyaluronan matrix, whereas low glucose and mannitol osmotic control cultures did not.

203 tol was admixed to MAC at 5, 10 and 20 wt% D-mannitol per total initial hydrogel weight.

204 The adenosine/mannitol permeability coefficient ratio (18/1) indicated

205 index of paracellular diffusion of ions, and mannitol permeability.

206 rate multispanning membrane proteins such as mannitol permease or TatC, which had been considered to

207 uation and chemical analysis (organic acids, mannitol, phenolic compounds, sugars and volatile compou

208 r 7 days (n=16) or equiosmolar free water/5% mannitol (placebo; n=15).

209 um chloride, tetraethyl ammonium bromide and mannitol, plus previously published data on six other co

210 ifferential scanning calorimetry showed that mannitol predominantly retained the beta-polymorph; howe

211 enous injection of rSV40s, particularly with mannitol pretreatment, resulted in extensive expression

212 or protein in Corynebacterium glutamicum for mannitol production from fructose and formate, and overe

213 regions following treatment, suggesting that mannitol promotes alpha-synuclein clearance in the cell

214 e noted in the rate of positive responses to mannitol provocation or Feno measurements.

215 the 2 sexes with airway hyperresponsiveness (mannitol provocation testing) or inflammation (Feno).

216 try, fractional exhaled nitric oxide (Feno), mannitol provocation testing, and (3)He gas magnetic res

217 ad-down r(2) = 0.58, P < 0.001; 10-month-old mannitol r(2) = 0.41, P < 0.001).

218 used test has been the urinary lactulose to mannitol ratio (L:M), which primarily assesses gut leaki

219 poridium and rotavirus, and the lactulose to mannitol ratio for intestinal permeability was determine

220 n 0-2 h levels of mannitol and the lactulose:mannitol ratio); SB permeability was greater in HLA-DQ2/

221 ired gut permeability, such as the lactulose/mannitol ratio, plasma endotoxin concentrations, and ser

222 tegrity [assessed by using urinary lactulose:mannitol ratios (LMRs)].

223 ol required to reach a 15% drop in FEV1 , or mannitol reactivity, expressed as the response dose rati

224 mainly produced delta and amorphous forms of mannitol, regardless of annealing.

225 Perfusion with phloridzin or 75 mM mannitol, removal of luminal Ca(2+), or inhibition of un

226 tivity, expressed as the provocative dose of mannitol required to reach a 15% drop in FEV1 , or manni

227 nitric oxide, airway hyperresponsiveness to mannitol, respiratory system mechanics using the forced

228 = 74) were negative to mannitol, and 16% of mannitol responders (n = 76) were negative to methacholi

229 The current investigation assessed mannitol responsiveness 24 h after allergen challenge.

230 We have shown mannitol responsiveness decreases 3 h after allergen inh

231 scular permeability via measurement of [(3)H]mannitol retina to lung (RLLR) and retina to renal leaka

232 The microstructure of mannitol ring-banded spherulites compares favorably to t

233 gerated conditions in saline adenine glucose mannitol (SAGM) additives have revealed the presence of

234 nth visits and cultured by direct plating to mannitol salt agar (MSA) and CHROMagar MRSA (CM) and ove

235 gar, colistin-nalidixic acid agar (CNA), and mannitol salt agar (MSA); and 25 enteric isolates grown

236 yptic soy agar with 5% sheep blood [SBA] and mannitol salt agar [MSA]).

237 m mannitol salt agar, and yellow isolates on mannitol salt agar at quantities of >1+ can be reported

238 GeneOhm MRSA PCR and various culture media (mannitol salt agar with cefoxitin, MRSASelect, CHROMagar

239 determined accurately by using isolates from mannitol salt agar, and yellow isolates on mannitol salt

240 We found no significant difference in mannitol sensitivity, expressed as the provocative dose

241 exposure of HASMCs to hyperglycemia but not mannitol significantly increased sphingosine kinase 1 (S

242 Preadministration of mannitol significantly increases the number of hBMSCs lo

243 In parallel, high glucose, but not mannitol, significantly increased superoxide and 3-nitro

244 of MUPP1 expression included NaCl, sucrose, mannitol, sodium acetate, and choline chloride but not u

245 were -2.89, -0.68, 2.18, 3.12, and 4.02 for mannitol, sodium fluorescein, budesonide, celecoxib, and

246 In addition, mannitol solid-state form ratios were semiquantitatively

247 been disrupted by exposure to a hyperosmolar mannitol solution, permitting the transluminal transport

248 No harmful effect was found with mannitol solutions.

249 Binding studies of sugar alcohols mannitol, sorbitol, erythritol, adonitol, arabitol, gala

250 hat the commonly used stress-inducing agents mannitol, sorbitol, NaCl, and hydrogen peroxide impact s

251 arterial blood pressure whereas equi-osmotic mannitol/sorbitol did not alter any variable.

252 erial blood pressure (ABP) than equi-osmotic mannitol/sorbitol.

253 pressor response than infusion of hypertonic mannitol/sorbitol.

254 lated region of the mtl operon, encoding the mannitol-specific phosphotransferase system.

255 ding site, and inhibits the synthesis of the mannitol-specific phosphotransferase system.

256 The mannitol-specific PTS catalyze the uptake and phosphoryl

257 ation base containing d-glucose, d-xylose, d-mannitol, sucrose, lactose, or maltose.

258 We investigated concentrations of mannitol, sucrose, trehalose and sorbitol from 1:1 to 30

259 nd aequorin, and exploiting a D-lactate- and mannitol/sucrose-based bioenergetic shunt that greatly m

260 lA protein is present only in cells grown on mannitol sugar, whereas MtlS sRNA is expressed during gr

261 wed greater inhibition when grown on NaCl or mannitol, suggesting a role in osmotic stress resistance

262 ct on bacterial survival but protection by d-mannitol suggests hydroxyl radicals are involved in the

263 almonella species but partial quenching by d-mannitol suggests radicals other than hydroxyl may be in

264 ionation, we grew wild-type and a transgenic mannitol synthesizer Arabidopsis thaliana hydroponically

265 asures of intestinal permeability (lactulose:mannitol test, plasma zonulin, and plasma lipopolysaccha

266 the cascade reaction and produces 60% more D-mannitol than the other complex with active sites direct

267 n SGLT1 compared with water or iso-osmotic D-mannitol; this effect was replicated by D-fructose or sa

268 Administration of mannitol to 11-month-old mice resulted in a reduction in

269 r without prior intraperitoneal injection of mannitol to deliver transgenes to the central nervous sy

270 croMRI) in AD transgenic mice, where we used mannitol to enhance blood brain barrier (BBB) permeabili

271 Switching perfusion from mannitol to glucose (75 mM) exerted similar effects.

272 Here, we examined the ability of mannitol to interfere with the aggregation process of al

273 The Escherichia coli mannitol transporter (II(Mtl)) comprises three domains c

274 phorylated B (phospho-IIBMtl) domains of the mannitol transporter of the Escherichia coli phosphotran

275 rotein interaction, whereas exogenous ABA or mannitol treatment restored this interaction.

276 rylation events responsive to 5 min of 0.3 m mannitol treatment were first identified using (15)N met

277 Hypertonic saline use increased and mannitol use decreased with publication of the 2003 guid

278 billing for parenteral hypertonic saline and mannitol use, by day of service.

279 the number of specialty care consultations, mannitol use, treatment with barbiturate coma, decompres

280 d with glucose (150, 310, and 1000 mOsm) and mannitol used as an osmotic control agent in both experi

281 GW4 grown heterotrophically with mannitol used As(III) as a supplemental energy supply as

282 Mannitol, used as an osmotic control, did not cause sign

283 ilm formation defects, as well as changes in mannitol utilization.

284 Absorptive fluxes of both oxalate and mannitol varied in parallel in different segments of sma

285 D-mannitol was admixed to MAC at 5, 10 and 20 wt% D-mannit

286 For instance, mannitol was found to have a permeability coefficient of

287 sos3-1 shs1-1 root growth to LiCl, KCl, and mannitol was not significantly different from growth of

288 nealing step on the solid-state formation of mannitol was studied.

289 ida was also measured and result showed that mannitol was the only free carbohydrate in U. pinnatifid

290 flux of oxalate in duodenum exceeded that of mannitol, was sensitive to DIDS, and saturable, indicati

291 in with 5-25 mmol/L d-glucose or iso-osmolar mannitol, we evaluated the influence of a 30-min incubat

292 and the effects of additives azide ion and d-mannitol were examined to help clarify the photokilling

293 -homonojirimycin and 2,5-dideoxy-2,5-imino-d-mannitol were the major iminosugars determined.

294 pertonic conditions (by addition of 300 mOsm mannitol), which increases intracellular protein crowdin

295 ty (LSNA) by 32 +/- 5% (NaCl) and 21 +/- 1% (mannitol), which was attenuated after precollicular tran

296 on of 10 mM Ca(2+), nor clearance of [(14)C]-mannitol, which was less than 0.7% of the rate of glucos

297 Nanoporous mannitol with a mean pore size of about 6 nm exhibited 0

298 ombic and monoclinic crystal structures of d-mannitol with data acquisition times of <7 s per field o

299 nique was firstly used to prepare nanoporous mannitol with small asperities to enhance the DPI aeroso

300 cteria including Mycobacterium tuberculosis; mannitol, with selective uptake in S. aureus and E. coli